NEW YORK-, a developer of adult stem cell technologies and therapeutics, announced in October that it has entered into a strategic agreement with , a Good Laboratory Practice contractor, in order to complete pre-clinical safety experiments for the company's ...
[Drug Discovery News - 11/05/2009]